Multiple Sclerosis Immunology A Foundation for Current and Future Treatments /

The availability of powerful genome-wide association study technology, during the last five years, has shown that most of the "new" MS susceptibility loci are immune-response genes. It is clear that there is much novelty in the field of MS immunology, which has served as an impetus to inve...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Yamamura, Takashi (Editor ), Gran, Bruno (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer New York : Imprint: Springer, 2013.
Edición:1st ed. 2013.
Temas:
Immunology.
Medical genetics.
Medicine-Research.
Biology-Research.
Medical Genetics.
Biomedical Research.
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • Th17 cells in autoimmune inflammation and demyelination in the central nervous system
  • Regulatory T cells in MS
  • T-bet: A critical regulator of encephalitogenic T Cells
  • Antigen-presenting cells in the Central Nervous System
  • The role of B cells in multiple sclerosis
  • Diet, gut flora and multiple sclerosis: current research and future perspectives
  • GM-CSF in autoimmune inflammation of the central nervous system
  • The role of Toll-like receptors in multiple sclerosis and experimental autoimmune encephalomyelitis
  • Macrophages and microglia in experimental autoimmune encephalomyelitis and multiple sclerosis
  • Genetics of multiple sclerosis
  • Gene expression profiling and pathway analysis for identification of molecular targets in MS
  • Systems biology for the study of multiple sclerosis
  • Checkpoints in the development of pathogenic and regulatory T cells in Experimental Autoimmune Encephalomyelitis-a basis for current future interventions in MS
  • Modeling MS in non-human primates
  • A novel concept of treatment in MS: targeting both oligodendrocyte death and inflammatory processes by inhibiting poly (ADP-Ribose) polymerase
  • Association of MS with other autoimmune diseases
  • Current and future treatments of Multiple Sclerosis
  • Targeting CD52 for the treatment of Multiple Sclerosis
  • Haematopoietic stem cells for the treatment of MS
  • Mesenchymal stem cells for the treatment of Multiple Sclerosis.

Ejemplares similares